STOCK TITAN

Butterfly Network Inc - BFLY STOCK NEWS

Welcome to our dedicated page for Butterfly Network news (Ticker: BFLY), a resource for investors and traders seeking the latest updates and insights on Butterfly Network stock.

About Butterfly Network Inc.

Butterfly Network Inc. (NYSE: BFLY) is a transformative digital health company dedicated to democratizing access to medical imaging through its innovative, semiconductor-based ultrasound technology. Founded in 2011, the company has developed the world's first handheld, whole-body ultrasound system, powered by its proprietary Ultrasound-on-Chip™ technology. This groundbreaking solution combines advanced hardware, cloud-connected software, and artificial intelligence (AI) to deliver high-quality imaging at a fraction of the cost of traditional ultrasound systems. Butterfly's mission is to make medical imaging globally accessible, addressing the needs of the 4.7 billion people worldwide who currently lack access to ultrasound technology.

Core Technology and Products

At the heart of Butterfly Network's innovation is its Ultrasound-on-Chip™ technology, which miniaturizes the complex components of traditional ultrasound machines into a single semiconductor chip. This enables the creation of portable, handheld devices like the Butterfly iQ+, capable of performing whole-body imaging with a single probe. Designed for ease of use, these devices integrate seamlessly with mobile applications, empowering healthcare professionals to capture and interpret diagnostic-quality images at the point of care. The cloud-based platform further enhances functionality by enabling secure storage, sharing, and analysis of imaging data, fostering collaboration and remote diagnostics.

Business Model and Revenue Streams

Butterfly Network's business model is built on a combination of hardware sales, software subscriptions, and strategic partnerships. The company generates revenue through the sale of its handheld ultrasound devices, which are complemented by subscription-based access to its cloud platform and AI-powered tools. Additionally, the Butterfly Garden AI marketplace allows third-party developers to create and deploy AI applications that integrate with Butterfly's imaging platform, unlocking new functionalities and expanding its ecosystem. This multi-faceted approach not only drives recurring revenue but also positions Butterfly as a hub for innovation in digital health.

Market Impact and Competitive Positioning

Butterfly Network operates within the rapidly evolving landscape of point-of-care diagnostics and telemedicine. Its portable and affordable ultrasound devices address critical bottlenecks in healthcare, such as the high cost of traditional imaging systems, limited access in underserved regions, and a global shortage of trained sonographers. By enabling more healthcare professionals to perform diagnostic imaging, Butterfly is improving patient outcomes and reducing delays in care. The company's commitment to education, exemplified by initiatives like the AI-powered ScanLab™ app, further differentiates it by equipping medical professionals with the skills needed to maximize the utility of its technology.

Partnerships and Ecosystem Development

Butterfly Network's collaborative approach amplifies its impact. Recent partnerships, such as the integration of UltraSight's AI guidance software, highlight its focus on expanding the capabilities of its platform. The Butterfly Garden marketplace fosters innovation by providing developers with access to its proprietary SDK and APIs, enabling the creation of specialized AI applications. These collaborations not only enhance the functionality of Butterfly's devices but also strengthen its competitive position by creating a robust ecosystem of interconnected solutions.

Challenges and Opportunities

While Butterfly Network faces challenges such as regulatory compliance, market competition, and the need for widespread adoption of its technology, its unique value proposition positions it for long-term success. The company's focus on affordability, portability, and AI-driven insights aligns with global healthcare trends, including the shift towards value-based care and the increasing emphasis on early detection and remote monitoring. By addressing systemic barriers to medical imaging, Butterfly is poised to play a pivotal role in shaping the future of healthcare delivery.

Conclusion

Butterfly Network Inc. represents a paradigm shift in medical imaging, leveraging cutting-edge technology to make high-quality ultrasound accessible, affordable, and easy to use. Through its innovative products, strategic partnerships, and commitment to education, the company is not only transforming diagnostics but also advancing global health equity. As healthcare systems worldwide grapple with increasing demand for cost-effective and scalable solutions, Butterfly's holistic approach positions it as a leader in the digital health revolution.

Rhea-AI Summary
Butterfly Network, Inc. launches Butterfly iQ3, a third-generation handheld point-of-care ultrasound system powered by advanced semiconductor chip technology. The device offers unparalleled image quality, faster micro-beamforming, and new 3D imaging capabilities. Butterfly iQ3 is available for purchase in the United States at $3,899 plus membership, aiming to revolutionize point-of-care ultrasound with enhanced comfort, efficiency, and innovative tools.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.08%
Tags
none
-
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) expects to exceed 2023 revenue and adjusted EBITDA guidance. The company showcased the sharp image quality of its newly FDA-cleared, third-generation probe, Butterfly iQ3, and introduced iQ Slice, the world’s first automated, sequential image capture mode on a handheld ultrasound, launching with Butterfly iQ3. Joseph DeVivo, Butterfly Network’s President, CEO, and Chairman, expressed confidence in the team's performance and energy, leading to the expectation of exceeding the 2023 guidance provided. The company’s previously issued guidance for the full year 2023 was revenue of at least $64 million, and an improved adjusted EBITDA loss of $75 - 70 million. Butterfly also announced FDA clearance of its next-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3, and expects to launch it this quarter (Q1 2024).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.83%
Tags
none
-
Rhea-AI Summary
Butterfly Network, Inc. (BFLY) announces FDA clearance for Butterfly iQ3, a next-generation handheld point-of-care ultrasound system. The new device features advanced semiconductor technology, improved image resolution, sensitivity, and penetration, as well as faster 3D capabilities. It also introduces novel, automated image capture modes: iQ Slice and iQ Fan. Butterfly iQ3 is set to revolutionize digital ultrasound and make it more accessible and approachable than ever before.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20.79%
Tags
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) will host one-on-one investor meetings at the 26th Annual Needham Growth Conference on January 16, 2024. The company is a digital health company specializing in handheld, whole-body ultrasound and intuitive software.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.98%
Tags
conferences
-
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) and Mendaera partner to bring Butterfly’s Ultrasound-on-Chip™ to the robotic intervention market, with revenue anticipated from every unit sold. The partnership aims to streamline patient care by improving precision and consistency for a broad range of image-guided, needle-based interventions. FDA submission of the product is anticipated by 2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.13%
Tags
none
-
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on January 8-11, 2024, in San Francisco. Joseph DeVivo, President & Chief Executive Officer, and Heather Getz, Executive Vice President & Chief Financial Officer, will present on January 11, 2024, at 9:00 AM PST. A webcast of the presentation will be available on the Butterfly investor website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.56%
Tags
conferences
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) will participate at the Jefferies London Healthcare Conference on November 14-16, 2023. CEO Joseph DeVivo and CFO Heather Getz will present on November 14 at 3:30 PM GMT. A live webcast will be available on the Butterfly Network investor website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary
Butterfly Network, Inc. announced financial results for Q3 2023, reporting a total revenue of $15.4 million, down from $19.6 million in the same period last year. The company completed a cost reduction and reorganization, allowing them to extend their cash to 2026. Butterfly also announced a five-year co-development agreement with Forest Neurotech and the launch of Butterfly Garden, an AI marketplace. They introduced two new ultrasound education offerings and submitted iQ3 for FDA approval.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.58%
Tags
-
Rhea-AI Summary
Butterfly Network and Forest Neurotech announce a five-year co-development agreement to develop the first implanted, whole-brain neural interface. The deal includes $20MM in milestones paid to Butterfly, with additional revenue anticipated upon commercialization for every unit sold.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.78%
Tags
none
Rhea-AI Summary
Butterfly Network to report Q3 2023 financial results and provide business update
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.84%
Tags
conferences earnings

FAQ

What is the current stock price of Butterfly Network (BFLY)?

The current stock price of Butterfly Network (BFLY) is $3.04 as of March 3, 2025.

What is the market cap of Butterfly Network (BFLY)?

The market cap of Butterfly Network (BFLY) is approximately 817.9M.

What does Butterfly Network Inc. do?

Butterfly Network Inc. develops portable, semiconductor-based ultrasound devices and cloud-connected software to democratize access to medical imaging.

How does Butterfly Network generate revenue?

The company generates revenue through device sales, subscription-based access to its cloud platform, and partnerships via its Butterfly Garden AI marketplace.

What is Ultrasound-on-Chip technology?

Ultrasound-on-Chip technology miniaturizes traditional ultrasound components into a semiconductor chip, enabling portable and affordable handheld devices.

What are the key benefits of Butterfly's handheld ultrasound devices?

Butterfly's devices offer affordability, portability, and AI-driven insights, making high-quality imaging accessible at the point of care for improved diagnostics.

Who are Butterfly Network's competitors?

Competitors include traditional ultrasound manufacturers and emerging digital health companies focusing on portable imaging solutions.

What is the Butterfly Garden AI marketplace?

The Butterfly Garden AI marketplace allows third-party developers to create and deploy AI applications that integrate with Butterfly's imaging platform.

How does Butterfly address the global shortage of sonographers?

Butterfly's AI-powered tools and educational initiatives enable more healthcare professionals, including novices, to perform diagnostic-quality imaging.

What industries benefit from Butterfly's technology?

Butterfly's technology benefits healthcare sectors such as emergency medicine, primary care, cardiology, and global health initiatives in underserved regions.

What challenges does Butterfly Network face?

Challenges include regulatory compliance, competition from traditional manufacturers, and the need for widespread adoption of its innovative technology.

What makes Butterfly Network unique in the medical imaging market?

Butterfly's unique value proposition lies in its affordable, portable devices powered by Ultrasound-on-Chip technology and its integration of AI and cloud-based solutions.
Butterfly Network Inc

NYSE:BFLY

BFLY Rankings

BFLY Stock Data

817.86M
184.87M
15.11%
23.86%
8.59%
Medical Devices
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States
BURLINGTON